Codes / ICD10CM / M05.11

M05.11 Rheumatoid lung disease with rheumatoid arthritis of shoulder

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Rheumatoid lung disease with rheumatoid arthritis of shoulder

Summary

Rheumatoid lung disease with rheumatoid arthritis of shoulder is a pulmonary manifestation of rheumatoid arthritis (RA), an autoimmune disorder. It involves inflammation and damage to lung tissue, potentially affecting structures such as the pleura, interstitium, or airways. This condition may occur alongside joint symptoms or as a complication of RA, reflecting systemic immune-mediated effects.

Causes

The exact cause of rheumatoid lung disease is not fully understood. It is believed to result from chronic inflammation and immune dysregulation associated with rheumatoid arthritis, leading to tissue damage in the lungs. Autoantibodies and inflammatory cytokines may contribute to lung involvement, though the precise mechanisms remain under investigation.

Risk Factors

  • Long-standing rheumatoid arthritis
  • High disease activity or severity of RA
  • Presence of rheumatoid factor (RF) or anti-citrullinated protein antibodies (ACPA)
  • Smoking
  • Advanced age
  • Male gender (in some subtypes)

Symptoms

  • Chronic cough
  • Shortness of breath (dyspnea)
  • Chest pain or discomfort
  • Fatigue
  • Unexplained weight loss
  • Clubbing of fingers (in advanced cases)

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging, and laboratory tests. High-resolution computed tomography (HRCT) of the chest may reveal characteristic patterns of lung involvement. Pulmonary function tests assess respiratory function. Blood tests for rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA) support the diagnosis. Biopsy may be considered in unclear cases.

Treatment Options

Treatment focuses on managing underlying rheumatoid arthritis and addressing lung symptoms. Medications include disease-modifying antirheumatic drugs (DMARDs) to control systemic inflammation. Corticosteroids or immunosuppressants may reduce lung inflammation. Oxygen therapy or pulmonary rehabilitation may alleviate respiratory symptoms. Smoking cessation is critical to slow disease progression.

Prognosis and Follow-Up

Prognosis varies based on disease severity and response to treatment. Early intervention can improve outcomes, but some patients experience progressive lung damage. Regular monitoring with imaging and pulmonary function tests is essential to track disease activity. Follow-up care should address both joint and respiratory symptoms to optimize quality of life.

Complications

  • Progressive respiratory failure
  • Pulmonary hypertension
  • Increased risk of infections
  • Cor pulmonale (right-sided heart failure)
  • Reduced exercise tolerance

Lifestyle & Prevention

  • Avoid smoking and secondhand smoke
  • Maintain a healthy weight to reduce respiratory strain
  • Engage in regular, low-impact exercise to support lung function
  • Follow a balanced diet to support overall health
  • Adhere to prescribed RA treatments to minimize systemic inflammation

When to Seek Professional Help

Seek medical attention if you experience worsening shortness of breath, persistent cough, chest pain, or unexplained weight loss. Prompt evaluation is crucial for early intervention and management of potential complications.

Tips for Medical Coders

Document the presence of rheumatoid arthritis of the shoulder and associated lung disease to support code assignment. Ensure clinical documentation specifies the relationship between the joint and pulmonary manifestations. Include details on diagnostic findings, such as imaging or laboratory results, to confirm the condition.

Book a walkthrough

M05.11 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.